Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP389560.RAubIbV3dej58dJDl1cbPMH_MXEeuuMDW5hhp92nNb20k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP389560.RAubIbV3dej58dJDl1cbPMH_MXEeuuMDW5hhp92nNb20k130_assertion type Assertion NP389560.RAubIbV3dej58dJDl1cbPMH_MXEeuuMDW5hhp92nNb20k130_head.
- NP389560.RAubIbV3dej58dJDl1cbPMH_MXEeuuMDW5hhp92nNb20k130_assertion description "[Furthermore, combinations of PT-20210A or FVL with PAI-1 (4G/4G) were significantly more frequent in APS patients (5.8%) than in normal controls (0.5%, p=0.016).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389560.RAubIbV3dej58dJDl1cbPMH_MXEeuuMDW5hhp92nNb20k130_provenance.
- NP389560.RAubIbV3dej58dJDl1cbPMH_MXEeuuMDW5hhp92nNb20k130_assertion evidence source_evidence_literature NP389560.RAubIbV3dej58dJDl1cbPMH_MXEeuuMDW5hhp92nNb20k130_provenance.
- NP389560.RAubIbV3dej58dJDl1cbPMH_MXEeuuMDW5hhp92nNb20k130_assertion SIO_000772 11454529 NP389560.RAubIbV3dej58dJDl1cbPMH_MXEeuuMDW5hhp92nNb20k130_provenance.
- NP389560.RAubIbV3dej58dJDl1cbPMH_MXEeuuMDW5hhp92nNb20k130_assertion wasDerivedFrom befree-20150227 NP389560.RAubIbV3dej58dJDl1cbPMH_MXEeuuMDW5hhp92nNb20k130_provenance.
- NP389560.RAubIbV3dej58dJDl1cbPMH_MXEeuuMDW5hhp92nNb20k130_assertion wasGeneratedBy ECO_0000203 NP389560.RAubIbV3dej58dJDl1cbPMH_MXEeuuMDW5hhp92nNb20k130_provenance.